Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Lancet Diabetes Endocrinol 2022;10:193-206
The initiation dose is sub-therapeutic
MT1 has been studied for its interaction with MC1R on immune cells, with research suggesting potential anti-inflammatory properties
It will often be prescribed with the intention of being a long-term medication if the patient responds well and is able to continue increasing the dosage until it is maximized
Supporting Adherence and Treatment Satisfaction Effective management of side effects improves adherence and overall treatment satisfaction
US$ 20.06
US$ 24.95
US$ 24.84
US$ 25.48
US$ 22.02
US$ 26.64
